Limerick BioPharma

About:

Limerick BioPharma develops compounds which can be used adjunctively with marketed and investigational drugs.

Website: http://www.limerickbio.com

Top Investors: ARCH Venture Partners, Sevin Rosen Funds, Altitude Life Science Ventures, OVP Venture Partners

Description:

Limerick BioPharma is dedicated to developing compounds that, when used adjunctively with both marketed and investigational drugs, significantly improve the quality of patients' lives. Their compounds minimize toxic side effects at non-targeted vulnerable organs and tissue while maintaining or enhancing a drug's desired effects. In the monotherapy setting, they are developing novel compounds that target the treatment of metabolic diseases such as hypercholesteremia and hyperglycemia.